The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer

Area of Science:

• Molecular Biology
• Oncology
• Cell Signaling

Background:

• Stem cell factor (SCF) interacts with the tyrosine kinase receptor c-KIT, initiating signaling cascades.
• SCF/c-KIT signaling regulates crucial cellular processes like proliferation, apoptosis, differentiation, and migration.
• Aberrant c-KIT activation, through mutations or overexpression, is implicated in various cancers.

Purpose of the Study:

• To review signaling pathways activated by the SCF/c-KIT system.
• To discuss the therapeutic potential of c-KIT inhibitors in male cancers.
• To highlight tr-KIT as a specific drug target in prostate cancer.

Main Methods:

• Literature review of SCF/c-KIT signaling pathways.
• Analysis of c-KIT's role in testicular and prostatic cancers.
• Discussion of c-KIT inhibitors as a treatment strategy.

Main Results:

• SCF/c-KIT signaling involves PI3-K, Src, JAK/STAT, PLC-γ, and MAPK pathways.
• Overactivated c-KIT drives proliferation in male cancers, particularly via PI3-K and Src pathways.
• Truncated c-KIT (tr-KIT) is crucial for Src activity in prostate cancer.

Conclusions:

• Targeting the SCF/c-KIT pathway offers a potential therapeutic strategy for male cancers.
• c-KIT inhibitors may be effective in treating testicular and prostate cancers.
• The tumor-specific tr-KIT variant presents a promising target for novel drug development.